SAUDI LYMPHOMA/MYELOMA AND HEMATOPATOLOGY OVERVIEW 2024

OBJECTIVES

The objectives of this conference are as follows

• To provide updated information on the multidisciplinary diagnostic and therapeutic options for lymphoproliferative disorders.
• To facilitate increased communication, collaboration, and exchange of knowledge and experience among hematologists, oncologists, pathologists, scientists, and other healthcare providers in the region.
• To promote education and awareness among hematopathologists regarding the diagnosis of various hematology disorders.
• To enable hematopathologists to understand the classification and differentiation of various diagnostics.
• To learn the utilization of various histopathological, flow cytometric, molecular, and other lab markers in the diagnosis of hematological disorders.
• To update participants with the latest diagnostic tools in hematopathology.

WHO SHOULD ATTEND?

This educational program is intended for Hematologists, Hemato-Pathologists, Medical Oncologists, Radiation Oncologists, Nuclear Medicine Specialists, Fellows and Residents in Training, Lab Scientists, Lab Technicians and technologists, and other healthcare providers who are involved in and/or interested in hematological disorders and SCT. State of the art lectures, evidence-based hematology sessions, and satellite symposia covering the latest technological developments will be the main features of the program.

Location